Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	keratinization	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.06e-28	87	51	17	GO:0031424
GeneOntologyBiologicalProcess	keratinocyte differentiation	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.23e-22	189	51	17	GO:0030216
GeneOntologyBiologicalProcess	epidermal cell differentiation	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.38e-19	284	51	17	GO:0009913
GeneOntologyBiologicalProcess	skin development	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.39e-17	373	51	17	GO:0043588
GeneOntologyBiologicalProcess	epidermis development	ELAPOR2 LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.97e-17	461	51	18	GO:0008544
GeneOntologyBiologicalProcess	epithelial cell differentiation	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.39e-11	870	51	17	GO:0030855
GeneOntologyBiologicalProcess	epithelium development	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	4.10e-08	1469	51	17	GO:0060429
GeneOntologyBiologicalProcess	interkinetic nuclear migration	TACC2 PCM1	2.66e-04	10	51	2	GO:0022027
GeneOntologyBiologicalProcess	astral microtubule organization	RAB11A TACC2	4.59e-04	13	51	2	GO:0030953
GeneOntologyBiologicalProcess	cytoplasmic microtubule organization	RAB11A TACC2 PCM1	5.84e-04	66	51	3	GO:0031122
GeneOntologyBiologicalProcess	regulation of endosome size	PCLO RAB11A	6.17e-04	15	51	2	GO:0051036
MousePheno	increased total body fat amount	STAU2 LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	1.17e-06	424	37	9	MP:0010024
MousePheno	decreased bone mineral content	STAU2 LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	2.50e-06	465	37	9	MP:0010124
MousePheno	abnormal bone mineral content	STAU2 LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	7.61e-05	713	37	9	MP:0010122
Domain	LCE	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	8.03e-42	17	50	16	PF14672
Domain	LCE	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	8.03e-42	17	50	16	IPR028205
Domain	SPRR/LCE	LCE4A LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.41e-35	28	50	16	IPR026075
Domain	Transcription_factor_COE	EBF3 EBF1	4.20e-05	4	50	2	IPR003523
Domain	COE1_HLH	EBF3 EBF1	4.20e-05	4	50	2	PF16423
Domain	COE1_DBD	EBF3 EBF1	4.20e-05	4	50	2	PF16422
Domain	COE_HLH	EBF3 EBF1	4.20e-05	4	50	2	IPR032201
Domain	COE_DBD	EBF3 EBF1	4.20e-05	4	50	2	IPR032200
Domain	COE	EBF3 EBF1	4.20e-05	4	50	2	PS01345
Domain	Transcription_factor_COE_CS	EBF3 EBF1	4.20e-05	4	50	2	IPR018350
Domain	Man6P_isomerase_rcpt-bd_dom	ELAPOR2 ELAPOR1	1.95e-04	8	50	2	IPR009011
Domain	zf-C2H2_11	ZNF354A ZNF667	2.50e-04	9	50	2	PF16622
Domain	Growth_fac_rcpt_	VLDLR ELAPOR2 ELAPOR1 ADGRE1	8.00e-04	156	50	4	IPR009030
Domain	zf-RanBP	RANBP2 ZRANB3	1.57e-03	22	50	2	PF00641
Domain	ZnF_RBZ	RANBP2 ZRANB3	1.71e-03	23	50	2	SM00547
Domain	ZF_RANBP2_2	RANBP2 ZRANB3	1.71e-03	23	50	2	PS50199
Domain	ZF_RANBP2_1	RANBP2 ZRANB3	1.87e-03	24	50	2	PS01358
Domain	Ephrin_rec_like	ELAPOR2 ELAPOR1	2.03e-03	25	50	2	SM01411
Domain	Znf_RanBP2	RANBP2 ZRANB3	2.03e-03	25	50	2	IPR001876
Domain	Tyr-kin_ephrin_A/B_rcpt-like	ELAPOR2 ELAPOR1	2.03e-03	25	50	2	IPR011641
Domain	IPT	EBF3 EBF1	2.36e-03	27	50	2	SM00429
Domain	TIG	EBF3 EBF1	3.11e-03	31	50	2	PF01833
Domain	IPT	EBF3 EBF1	3.31e-03	32	50	2	IPR002909
Domain	HLH	EBF3 EBF1 MLXIP	3.70e-03	116	50	3	SM00353
Domain	EGF_CA	VLDLR HABP2 ADGRE1	4.26e-03	122	50	3	SM00179
Domain	EGF-like_Ca-bd_dom	VLDLR HABP2 ADGRE1	4.46e-03	124	50	3	IPR001881
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.74e-23	129	38	16	M27649
Pathway	REACTOME_KERATINIZATION	LCE4A LCE3D LCE5A KRTAP26-1 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.76e-21	217	38	17	M27640
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	VLDLR LCE4A LCE3D LCE5A KRTAP26-1 EBF1 GRIN2B MED13L ITGA9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F ZFPM2 LCE2A LCE3E LCE2B	4.17e-14	1432	38	23	M509
Pubmed	Late cornified envelope family in differentiating epithelia--response to calcium and ultraviolet irradiation.	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	5.04e-42	22	53	16	15854049
Pubmed	Differentially expressed late constituents of the epidermal cornified envelope.	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.66e-41	23	53	16	11698679
Pubmed	Rodent Lce gene clusters; new nomenclature, gene organization, and divergence of human and rodent genes.	LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE2A LCE3E LCE2B	2.69e-35	16	53	13	17410201
Pubmed	Assessment of community efforts to advance network-based prediction of protein-protein interactions.	LCE4A LCE3D ICAM4 LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	4.10e-20	630	53	19	36949045
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E TMEM63A	1.10e-13	1031	53	17	16710414
Pubmed	CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins.	LCE4A LCE5A LCE1B LCE2C LCE3A	1.42e-13	7	53	5	36804407
Pubmed	Association between LCE gene polymorphisms and psoriasis vulgaris among Mongolians from Inner Mongolia.	LCE3D LCE1C LCE1B LCE3A	4.80e-12	4	53	4	29397434
Pubmed	Molecular cloning and characterization of a novel mouse epidermal differentiation gene and its promoter.	LCE3D LCE3B LCE3E	1.34e-08	4	53	3	11350120
Pubmed	Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells.	LCE3D LCE3B LCE3E	3.33e-08	5	53	3	11159194
Pubmed	Fate and plasticity of the epidermis in response to congenital activation of BRAF.	LCE3D LCE3B LCE3E	9.45e-07	13	53	3	25202828
Pubmed	p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis.	LCE3D LCE3B LCE3E	1.85e-06	16	53	3	21930775
Pubmed	Protein-protein interaction panel using mouse full-length cDNAs.	LCE5A LCE2D LCE2C LCE2A LCE2B	4.79e-06	161	53	5	11591653
Pubmed	Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity.	LCE3B LCE3A	6.83e-06	3	53	2	28634035
Pubmed	Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.	LCE3D LCE3A	6.83e-06	3	53	2	19169255
Pubmed	The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.	EBF3 EBF1	6.83e-06	3	53	2	9151732
Pubmed	Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition.	LCE3D LCE3B LCE3E	7.51e-06	25	53	3	23906066
Pubmed	Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18.	LCE3D LCE3B LCE3E	7.51e-06	25	53	3	23132931
Pubmed	Pax9 is required for filiform papilla development and suppresses skin-specific differentiation of the mammalian tongue epithelium.	LCE3D LCE3B LCE3E	8.47e-06	26	53	3	15454262
Pubmed	Increased Risk of Psoriasis due to combined effect of HLA-Cw6 and LCE3 risk alleles in Indian population.	LCE3B LCE3A	1.36e-05	4	53	2	27048876
Pubmed	Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection.	EBF3 EBF1	1.36e-05	4	53	2	12139918
Pubmed	Cloning and functional characterization of Roaz, a zinc finger protein that interacts with O/E-1 to regulate gene expression: implications for olfactory neuronal development.	EBF3 EBF1	1.36e-05	4	53	2	9151733
Pubmed	Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.	LCE3D LCE3B LCE3E	1.46e-05	31	53	3	20930145
Pubmed	Stem cell niche-specific Ebf3 maintains the bone marrow cavity.	EBF3 EBF1	2.27e-05	5	53	2	29563184
Pubmed	Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development.	EBF3 EBF1	2.27e-05	5	53	2	15261831
Pubmed	Formation of whisker-related principal sensory nucleus-based lemniscal pathway requires a paired homeodomain transcription factor, Drg11.	EBF3 EBF1	2.27e-05	5	53	2	12917357
Pubmed	The transcription factor, Lmx1b, is necessary for the development of the principal trigeminal nucleus-based lemniscal pathway.	EBF3 EBF1	3.40e-05	6	53	2	20621716
Pubmed	Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system.	EBF3 EBF1	3.40e-05	6	53	2	9389446
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	EBF3 EBF1	4.76e-05	7	53	2	24786561
Pubmed	Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-D-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes.	VLDLR GRIN2B	4.76e-05	7	53	2	23760271
Pubmed	Casein kinase 1δ functions at the centrosome and Golgi to promote ciliogenesis.	RAB11A PCM1	6.34e-05	8	53	2	24648492
Pubmed	Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection.	EBF3 EBF1	6.34e-05	8	53	2	14993187
Pubmed	TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation.	EBF3 EBF1	6.34e-05	8	53	2	32179550
Pubmed	Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.	VLDLR ZFPM2	6.34e-05	8	53	2	21757650
Pubmed	Superresolution imaging of chemical synapses in the brain.	PCLO GRIN2B	8.15e-05	9	53	2	21144999
Pubmed	The transcription factor EBF1 non-cell-autonomously regulates cardiac growth and differentiation.	HABP2 EBF1	1.02e-04	10	53	2	37787076
Pubmed	A POU domain transcription factor-dependent program regulates axon pathfinding in the vertebrate visual system.	EBF3 EBF1	1.02e-04	10	53	2	11163266
Pubmed	A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity.	LCE3D LCE3B LCE3E	1.19e-04	62	53	3	26644517
Pubmed	Control of hindbrain motor neuron differentiation by the homeobox gene Phox2b.	EBF3 EBF1	1.24e-04	11	53	2	10704382
Pubmed	Linx mediates interaxonal interactions and formation of the internal capsule.	EBF1 ZFPM2	1.24e-04	11	53	2	24930700
Pubmed	Transient and lineage-restricted requirement of Ebf3 for sternum ossification.	EBF3 EBF1	1.49e-04	12	53	2	32398354
Pubmed	An ancient role for collier/Olf/Ebf (COE)-type transcription factors in axial motor neuron development.	EBF3 EBF1	1.49e-04	12	53	2	30658714
Pubmed	Control of the migratory pathway of facial branchiomotor neurones.	EBF3 EBF1	1.76e-04	13	53	2	11076752
Pubmed	Early B-cell factors 2 and 3 (EBF2/3) regulate early migration of Cajal-Retzius cells from the cortical hem.	EBF3 EBF1	1.76e-04	13	53	2	22421355
Pubmed	The DNA sequence and comparative analysis of human chromosome 10.	ANTXRL EBF3 HABP2 TACC2 USP54	1.81e-04	345	53	5	15164054
Pubmed	Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation.	VLDLR ITGA9	2.05e-04	14	53	2	22665518
Pubmed	Exploration of human ORFeome: high-throughput preparation of ORF clones and efficient characterization of their protein products.	LCE3A LCE1F	2.36e-04	15	53	2	18316326
Pubmed	Ebf2 is required for development of dopamine neurons in the midbrain periaqueductal gray matter of mouse.	EBF3 EBF1	2.36e-04	15	53	2	25762221
Pubmed	Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein.	KCNA3 GRIN2B	2.36e-04	15	53	2	10479680
Pubmed	Molecular heterogeneity of developing retinal ganglion and amacrine cells revealed through single cell gene expression profiling.	EBF3 EBF1	2.70e-04	16	53	2	17444492
Pubmed	Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax.	ADGRE1 ITGA9	3.05e-04	17	53	2	21515254
Pubmed	The Transcription Factors EBF1 and EBF2 Are Positive Regulators of Myelination in Schwann Cells.	EBF3 EBF1	3.05e-04	17	53	2	27889898
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PCLO UBA3 USP54 ZFPM2 ZNF292	3.50e-04	398	53	5	35016035
Pubmed	Mice without macroH2A histone variants.	VLDLR EBF1	3.83e-04	19	53	2	25312643
Pubmed	Pathfinding of corticothalamic axons relies on a rendezvous with thalamic projections.	EBF1 ZFPM2	3.83e-04	19	53	2	23395374
Pubmed	A key role for the HLH transcription factor EBF2COE2,O/E-3 in Purkinje neuron migration and cerebellar cortical topography.	EBF3 EBF1	4.25e-04	20	53	2	16774995
Pubmed	Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients.	LCE5A LCE3A	4.70e-04	21	53	2	19601998
Pubmed	The Tbr2 Molecular Network Controls Cortical Neuronal Differentiation Through Complementary Genetic and Epigenetic Pathways.	EBF3 EBF1	4.70e-04	21	53	2	27600842
Pubmed	Identification of cellular proteins required for replication of human immunodeficiency virus type 1.	RAB11A UBA3	4.70e-04	21	53	2	22404213
Pubmed	DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport.	ADGRE1 ITGA9	4.70e-04	21	53	2	26529256
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PCLO GREB1 ZNF292	5.61e-04	105	53	3	9628581
Pubmed	Deletion of Stk40 impairs definitive erythropoiesis in the mouse fetal liver.	ICAM4 ADGRE1	5.65e-04	23	53	2	28358362
Pubmed	A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers.	RANBP2 UBA3	6.16e-04	24	53	2	16620772
Pubmed	Early B-cell factors are required for specifying multiple retinal cell types and subtypes from postmitotic precursors.	EBF3 EBF1	6.16e-04	24	53	2	20826655
Pubmed	Emx2 directs the development of diencephalon in cooperation with Otx2.	EBF3 EBF1	6.16e-04	24	53	2	11493561
Pubmed	Lmx1b controls the differentiation and migration of the superficial dorsal horn neurons of the spinal cord.	EBF3 EBF1	6.68e-04	25	53	2	15229182
Pubmed	Integrative genomic analysis of early neurogenesis reveals a temporal genetic program for differentiation and specification of preplate and Cajal-Retzius neurons.	EBF3 EBF1	7.80e-04	27	53	2	33760820
Pubmed	Dlx1/2 are Central and Essential Components in the Transcriptional Code for Generating Olfactory Bulb Interneurons.	EBF3 EBF1	8.40e-04	28	53	2	30796806
Pubmed	Identification of Arx transcriptional targets in the developing basal forebrain.	EBF3 EBF1	8.40e-04	28	53	2	18799476
Pubmed	EBF2 determines and maintains brown adipocyte identity.	EBF3 EBF1	9.01e-04	29	53	2	23499423
Pubmed	Defining the lineage of thermogenic perivascular adipose tissue.	EBF1 ADGRE1	9.01e-04	29	53	2	33846639
Pubmed	Multimodal Hox5 activity generates motor neuron diversity.	EBF3 EBF1	9.01e-04	29	53	2	39289460
Pubmed	TLR sorting by Rab11 endosomes maintains intestinal epithelial-microbial homeostasis.	RAB11A ADGRE1	9.64e-04	30	53	2	25063677
Pubmed	Necessity and Sufficiency of Ldb1 in the Generation, Differentiation and Maintenance of Non-photoreceptor Cell Types During Retinal Development.	EBF3 EBF1	9.64e-04	30	53	2	30127719
Pubmed	Embryonic forebrain transcriptome of mice with polyalanine expansion mutations in the ARX homeobox gene.	KCNA3 EBF1	1.03e-03	31	53	2	27798109
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	RANBP2 STAU2 HABP2 USP54	1.17e-03	302	53	4	30561431
Interaction	KRTAP5-2 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	2.44e-31	62	51	17	int:KRTAP5-2
Interaction	KRTAP4-4 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	2.48e-31	81	51	18	int:KRTAP4-4
Interaction	KRTAP5-4 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	3.34e-31	63	51	17	int:KRTAP5-4
Interaction	KRTAP5-6 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	4.79e-30	94	51	18	int:KRTAP5-6
Interaction	KRTAP4-5 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.23e-29	76	51	17	int:KRTAP4-5
Interaction	KRTAP9-8 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.62e-29	100	51	18	int:KRTAP9-8
Interaction	KRTAP10-11 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	9.21e-29	64	51	16	int:KRTAP10-11
Interaction	KRTAP1-5 interactions	LCE4A LCE3D LCE5A SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	1.18e-28	48	51	15	int:KRTAP1-5
Interaction	RGS17 interactions	LCE4A LCE3D LCE5A SMCP LCE1B LCE1E LCE1D LCE1A LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.18e-28	48	51	15	int:RGS17
Interaction	KRTAP5-3 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE3E LCE2B	1.61e-28	66	51	16	int:KRTAP5-3
Interaction	KRTAP4-11 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	4.43e-28	92	51	17	int:KRTAP4-11
Interaction	KRTAP4-2 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	3.44e-27	132	51	18	int:KRTAP4-2
Interaction	LCE2B interactions	LCE4A LCE3D LCE5A KRTAP26-1 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE2B	6.16e-27	81	51	16	int:LCE2B
Interaction	LCE2C interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE2B	2.62e-26	88	51	16	int:LCE2C
Interaction	KRTAP5-11 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E	2.81e-26	66	51	15	int:KRTAP5-11
Interaction	KRTAP9-2 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	3.43e-26	149	51	18	int:KRTAP9-2
Interaction	KRTAP10-1 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	5.65e-26	153	51	18	int:KRTAP10-1
Interaction	LCE2A interactions	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	5.91e-26	69	51	15	int:LCE2A
Interaction	KRTAP10-5 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.31e-25	160	51	18	int:KRTAP10-5
Interaction	KRTAP4-12 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.47e-25	161	51	18	int:KRTAP4-12
Interaction	LCE2D interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE2B	1.88e-25	74	51	15	int:LCE2D
Interaction	KRTAP9-3 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	9.07e-25	140	51	17	int:KRTAP9-3
Interaction	TRIM42 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	2.75e-24	149	51	17	int:TRIM42
Interaction	LCE3B interactions	LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2C LCE3B LCE3A LCE1F LCE2A LCE2B	3.16e-24	46	51	13	int:LCE3B
Interaction	KRTAP5-9 interactions	LCE4A LCE3D ICAM4 LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.10e-23	203	51	18	int:KRTAP5-9
Interaction	KRTAP5-7 interactions	LCE4A LCE3D SMCP LCE1B LCE1E LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	1.36e-23	71	51	14	int:KRTAP5-7
Interaction	LCE1C interactions	LCE4A LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE2B	4.68e-23	77	51	14	int:LCE1C
Interaction	LCE4A interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE2B	8.36e-23	80	51	14	int:LCE4A
Interaction	SPRY1 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E	1.32e-22	111	51	15	int:SPRY1
Interaction	KRTAP12-3 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	1.43e-22	146	51	16	int:KRTAP12-3
Interaction	LCE1B interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE1F LCE2A LCE2B	2.09e-22	85	51	14	int:LCE1B
Interaction	KRTAP10-9 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	2.59e-22	241	51	18	int:KRTAP10-9
Interaction	KRTAP10-6 interactions	LCE4A LCE3D LCE5A LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE1F LCE2A LCE3E LCE2B	3.52e-22	88	51	14	int:KRTAP10-6
Interaction	LCE5A interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE1F LCE2A LCE2B	4.93e-22	90	51	14	int:LCE5A
Interaction	LCE1F interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE1F LCE2A LCE2B	6.84e-22	92	51	14	int:LCE1F
Interaction	KRTAP4-1 interactions	LCE3D LCE5A SMCP LCE1B LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE3E	6.99e-22	31	51	11	int:KRTAP4-1
Interaction	LCE1E interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE1F LCE2B	9.37e-22	68	51	13	int:LCE1E
Interaction	KRTAP2-3 interactions	LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	1.10e-21	95	51	14	int:KRTAP2-3
Interaction	LCE1D interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE2D LCE2C LCE3B LCE1F LCE2A LCE2B	1.41e-21	70	51	13	int:LCE1D
Interaction	KRTAP1-1 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	2.34e-21	219	51	17	int:KRTAP1-1
Interaction	KRTAP2-4 interactions	LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	2.74e-21	101	51	14	int:KRTAP2-4
Interaction	KRTAP12-4 interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1A LCE2C LCE3A LCE1F LCE2A	4.21e-21	53	51	12	int:KRTAP12-4
Interaction	KRTAP1-3 interactions	LCE4A LCE3D LCE5A SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	6.53e-21	184	51	16	int:KRTAP1-3
Interaction	NBPF19 interactions	LCE4A LCE3D ICAM4 LCE5A KRTAP26-1 SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	6.82e-21	233	51	17	int:NBPF19
Interaction	KRTAP10-7 interactions	LCE4A LCE3D LCE5A ZNF667 KRTAP26-1 SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	9.04e-21	293	51	18	int:KRTAP10-7
Interaction	LCE1A interactions	LCE4A LCE5A SMCP LCE1C LCE1B LCE1E LCE1A LCE2D LCE2C LCE3B LCE1F LCE2A LCE2B	1.82e-20	84	51	13	int:LCE1A
Interaction	RGS20 interactions	LCE4A LCE3D LCE5A LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	2.71e-20	118	51	14	int:RGS20
Interaction	KRTAP12-1 interactions	LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1A LCE2C LCE3A LCE1F LCE2A LCE2B	4.14e-20	63	51	12	int:KRTAP12-1
Interaction	CYSRT1 interactions	LCE4A LCE3D ICAM4 LCE5A KRTAP26-1 SMCP USP54 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	3.13e-19	511	51	20	int:CYSRT1
Interaction	SMCP interactions	LCE4A LCE5A SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F	7.72e-19	79	51	12	int:SMCP
Interaction	KRTAP6-3 interactions	LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1A LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	2.43e-18	161	51	14	int:KRTAP6-3
Interaction	KRTAP10-8 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	2.50e-18	401	51	18	int:KRTAP10-8
Interaction	ALPP interactions	LCE4A LCE3D LCE5A SMCP LCE1C LCE1B LCE1E LCE1D LCE2C LCE3B LCE3A LCE1F LCE3E	3.33e-18	123	51	13	int:ALPP
Interaction	NOTCH2NLA interactions	LCE4A LCE3D ICAM4 LCE5A KRTAP26-1 SMCP LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	2.90e-17	381	51	17	int:NOTCH2NLA
Interaction	VASN interactions	LCE4A LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE2B	1.11e-16	160	51	13	int:VASN
Interaction	ADAMTSL4 interactions	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	1.68e-16	217	51	14	int:ADAMTSL4
Interaction	HOXA1 interactions	LCE4A LCE3D LCE5A KRTAP26-1 SMCP LCE1C LCE1B LCE1D LCE1A LCE2D LCE2C LCE3A LCE1F LCE2A LCE3E LCE2B	2.63e-16	356	51	16	int:HOXA1
Interaction	VWC2 interactions	LCE4A LCE3D LCE5A LCE1C LCE1A LCE2D LCE2C LCE3A LCE1F LCE3E	4.11e-16	62	51	10	int:VWC2
Interaction	CHIC2 interactions	LCE3D LCE5A LCE1C LCE1B LCE1D LCE1A LCE2C LCE3A LCE1F LCE3E	2.32e-15	73	51	10	int:CHIC2
Interaction	MACO1 interactions	LCE3D LCE5A RAB11A SMCP LCE1C LCE1E LCE1D LCE1A LCE2C LCE3A LCE1F LCE3E	1.49e-14	175	51	12	int:MACO1
Interaction	CRCT1 interactions	LCE4A LCE1C LCE1D LCE1A LCE2C LCE3A LCE1F LCE2A LCE2B	6.71e-14	66	51	9	int:CRCT1
Interaction	LCE3A interactions	LCE4A SMCP LCE1C LCE2D LCE2C LCE3B LCE3A LCE2A LCE2B	2.53e-13	76	51	9	int:LCE3A
Interaction	KRTAP17-1 interactions	LCE4A LCE3D LCE1B LCE1E LCE2D LCE2C LCE3A LCE2B	3.30e-13	48	51	8	int:KRTAP17-1
Interaction	KRTAP3-2 interactions	LCE4A LCE3D KRTAP26-1 LCE1B LCE1A LCE3A LCE1F LCE2A LCE3E	3.64e-13	79	51	9	int:KRTAP3-2
Interaction	SPRY3 interactions	LCE3D LCE1B LCE1A LCE3A LCE1F LCE3E LCE2B	2.76e-12	35	51	7	int:SPRY3
Interaction	GRN interactions	LCE4A LCE5A KRTAP26-1 SMCP LCE1B LCE1E LCE1D LCE1A LCE2D PCM1 LCE3E LCE2B	4.18e-12	281	51	12	int:GRN
Interaction	OTX1 interactions	LCE4A KRTAP26-1 USP54 LCE1C LCE1B LCE2D LCE2C LCE1F LCE2A LCE2B	5.27e-12	155	51	10	int:OTX1
Interaction	PLA2G10 interactions	LCE5A KRTAP26-1 LCE1C LCE1A LCE2D LCE3A LCE1F LCE2A LCE2B	9.90e-12	113	51	9	int:PLA2G10
Interaction	KRTAP12-2 interactions	LCE4A LCE5A KRTAP26-1 LCE1C LCE1B LCE1A LCE1F LCE2A LCE2B	3.07e-11	128	51	9	int:KRTAP12-2
Interaction	EFEMP2 interactions	LCE3D KRTAP26-1 LCE1C LCE1E LCE1A LCE2D LCE2C LCE3A LCE3E	5.32e-11	136	51	9	int:EFEMP2
Interaction	KRTAP10-10 interactions	LCE1C LCE1B LCE1E LCE2C LCE3B LCE1F	5.51e-11	27	51	6	int:KRTAP10-10
Interaction	CYP21A2 interactions	LCE3D LCE5A LCE1D LCE2C LCE3B LCE1F	2.04e-10	33	51	6	int:CYP21A2
Interaction	TGFB1 interactions	LCE3D LCE5A GREB1 LCE1C LCE1D LCE1A LCE2C LCE3B LCE3A LCE1F LCE2B	3.34e-10	317	51	11	int:TGFB1
Interaction	LCE3C interactions	LCE4A LCE5A LCE1B LCE1A LCE2D LCE1F LCE2B	3.35e-10	67	51	7	int:LCE3C
Interaction	KRTAP3-1 interactions	LCE4A LCE3D LCE5A KRTAP26-1 LCE1B LCE3A LCE2B	1.84e-09	85	51	7	int:KRTAP3-1
Interaction	TSPAN4 interactions	LCE4A LCE3D LCE1A LCE2D LCE3A LCE2B	4.06e-09	53	51	6	int:TSPAN4
Interaction	NECTIN2 interactions	KCNA3 LCE5A RAB11A LCE1C LCE1E LCE2C LCE1F LCE2B	6.01e-09	159	51	8	int:NECTIN2
Interaction	PLAC8 interactions	LCE5A USP54 LCE1C LCE1A LCE2B	6.57e-09	27	51	5	int:PLAC8
Interaction	KRTAP11-1 interactions	KRTAP26-1 LCE1B LCE1A LCE3A LCE1F LCE2A LCE2B	9.94e-09	108	51	7	int:KRTAP11-1
Interaction	PCSK5 interactions	LCE3D SMCP USP54 LCE1D LCE2C LCE3A LCE1F	1.28e-08	112	51	7	int:PCSK5
Interaction	SLC39A7 interactions	LCE4A LCE5A SMCP LCE1C LCE1A LCE2D LCE2C LCE1F	2.14e-08	187	51	8	int:SLC39A7
Interaction	FBLN1 interactions	LCE5A LCE1C LCE1B LCE1D LCE1A LCE3A LCE1F	3.42e-08	129	51	7	int:FBLN1
Interaction	VWC2L interactions	LCE3D LCE5A LCE1C LCE1A LCE3A	5.22e-08	40	51	5	int:VWC2L
Interaction	KRTAP3-3 interactions	LCE4A LCE3D LCE3A LCE1F LCE3E LCE2B	5.86e-08	82	51	6	int:KRTAP3-3
Interaction	PLSCR2 interactions	LCE5A LCE1A LCE3A LCE3E	6.47e-08	16	51	4	int:PLSCR2
Interaction	MDFI interactions	LCE4A LCE3D LCE1B LCE1D LCE1A LCE3A LCE1F LCE3E LCE2B BAALC	1.03e-07	430	51	10	int:MDFI
Interaction	SPRY2 interactions	LCE4A LCE1C LCE1B LCE1A LCE2D LCE1F LCE3E	1.06e-07	152	51	7	int:SPRY2
Interaction	PLSCR3 interactions	LCE4A LCE5A SMCP LCE1C LCE2B	1.34e-07	48	51	5	int:PLSCR3
Interaction	CATSPER1 interactions	LCE5A LCE1B LCE1E LCE1D LCE2C LCE1F	7.58e-07	126	51	6	int:CATSPER1
Interaction	KRTAP5-8 interactions	LCE5A LCE1E LCE3A	8.47e-07	8	51	3	int:KRTAP5-8
Interaction	NUFIP2 interactions	LCE4A KCNA3 LCE5A LCE1B LCE1D LCE2D LCE2C LCE1F LCE2B	8.99e-07	417	51	9	int:NUFIP2
Interaction	KRTAP21-2 interactions	LCE5A KRTAP26-1 LCE1A LCE2A	1.09e-06	31	51	4	int:KRTAP21-2
Interaction	LCE3D interactions	LCE3D LCE2D LCE2C LCE2A LCE2B	1.12e-06	73	51	5	int:LCE3D
Interaction	KRTAP9-4 interactions	LCE4A SMCP LCE1B LCE3E	1.41e-06	33	51	4	int:KRTAP9-4
Interaction	GUCD1 interactions	SMCP LCE1C LCE2D LCE2A LCE2B	2.84e-06	88	51	5	int:GUCD1
Interaction	CREB5 interactions	LCE4A LCE5A LCE1C LCE2C LCE1F LCE2A	3.52e-06	164	51	6	int:CREB5
Interaction	FUCA2 interactions	LCE4A LCE1B LCE1E LCE1A	4.17e-06	43	51	4	int:FUCA2
Interaction	THSD1 interactions	KCNA3 RAB11A	3.76e-05	4	51	2	int:THSD1
Interaction	PLSCR4 interactions	LCE5A LCE1C LCE1A LCE2B	3.87e-05	75	51	4	int:PLSCR4
Interaction	POU4F2 interactions	LCE5A LCE1C LCE2C LCE1F	5.77e-05	83	51	4	int:POU4F2
Cytoband	1q21.3	LCE4A LCE5A SPRR4 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E	1.49e-29	117	53	16	1q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1q21	LCE4A SPRR5 LCE3D LCE5A SPRR4 SMCP LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	5.22e-26	404	53	19	chr1q21
Cytoband	1p13.3	KCNA3 ELAPOR1	2.92e-03	69	53	2	1p13.3
Cytoband	1q21	LCE3D LCE2B	5.01e-03	91	53	2	1q21
GeneFamily	Late cornified envelope proteins	LCE4A LCE3D LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE3B LCE3A LCE1F LCE2A LCE3E LCE2B	3.18e-43	18	37	16	627
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RANBP2 ZRANB3	8.35e-04	21	37	2	89
Coexpression	JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP	LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE2A LCE2B	2.36e-18	49	51	10	MM452
Coexpression	HOLLERN_SQUAMOUS_BREAST_TUMOR	LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	5.61e-09	204	51	8	MM966
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_UP	LCE5A RAB40C ITGA9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	7.13e-07	689	51	10	MM1041
Coexpression	MARTINEZ_TP53_TARGETS_UP	LCE5A RAB40C ITGA9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	7.61e-07	694	51	10	MM1039
Coexpression	MARTINEZ_RB1_TARGETS_DN	LCE5A LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C	2.73e-05	630	51	8	MM1038
Coexpression	GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP	PCLO GRIN2B ADGRE1 ZFPM2 LCE2B	4.35e-05	200	51	5	M4297
CoexpressionAtlas	skin	LCE4A LCE3D LCE5A SPRR4 LCE1C LCE1B LCE1E LCE1D LCE1A LCE2D LCE2C LCE1F LCE2A LCE3E LCE2B	1.64e-13	456	52	15	skin
CoexpressionAtlas	UniversalReference_WholeMouseP1_top-relative-expression-ranked_250	ICAM4 LCE1C LCE1B LCE1E LCE1D LCE1F	1.09e-05	206	52	6	Facebase_ST1_Univ_250
CoexpressionAtlas	UniversalReference_WholeMouseP1_top-relative-expression-ranked_500	ICAM4 LCE1C LCE1B LCE1E LCE1D LCE3A LCE1F	7.76e-05	427	52	7	Facebase_ST1_Univ_500
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3\|TCGA-Testes / Sample_Type by Project: Shred V9	LCE4A LCE1C LCE1D LCE1A LCE2D LCE2C LCE1F LCE2A LCE2B	2.94e-14	125	53	9	5f90de494b53ecce6455034f3ed5dccdbb2c29ca
ToppCell	TCGA-Skin-Primary_Tumor\|TCGA-Skin / Sample_Type by Project: Shred V9	LCE3D LCE1C LCE1A LCE2D LCE2C LCE3A LCE1F LCE3E LCE2B	1.33e-12	190	53	9	e2b26a03c6ab24d9b0f4150c47597be37767d86e
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	LCE3D LCE1C LCE1A LCE2D LCE2C LCE3A LCE1F LCE3E LCE2B	1.33e-12	190	53	9	01fb45add4661bc86cd0a34fac35177907152dbb
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	LCE3D LCE1C LCE1A LCE2D LCE2C LCE3A LCE1F LCE3E LCE2B	1.33e-12	190	53	9	3188c7bd225cbcf46a21e2fb784336cdd9665995
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	SPRR5 ELAPOR1 TACC2 USP54 ITGA9	2.45e-06	181	53	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	SMCP LCE2D LCE2C LCE2A	4.44e-06	92	53	4	b728c0faf742c9235b891e3acf34d18a0e335c22
ToppCell	TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor-Sarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	SMCP LCE2D LCE2C LCE2A	4.44e-06	92	53	4	207cde9de6f37b33e47bc6f9c32c9877ab7cbe63
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ZNF354A ZNF667 RAB40C ITGA9	1.11e-05	116	53	4	f32f7eddfe33adb3b5cf7c34667a481a305c5163
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	LCE3D LCE1A LCE3A LCE3E	3.57e-05	156	53	4	ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0
ToppCell	lymphoid-B_cell-pro-B\|World / Lineage, cell class and subclass	PCLO EBF1 MLXIP BAALC	4.03e-05	161	53	4	23138e579f07d5a6f20d41457cb573b4ac95a4ef
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	LCE3D LCE1C LCE1F LCE3E	4.34e-05	164	53	4	de1646dbcf2a10b48e021acf7dc63e803e6a47ce
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANTXRL EBF3 EBF1 ITGA9	4.55e-05	166	53	4	8e2faca6a2e76a625de04d6098aa6f98911945c6
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-6\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	LCE3D LCE2D LCE3A LCE3E	4.99e-05	170	53	4	3dba3f810fbd1eadf446b52e4c9c971d362a80e1
ToppCell	TCGA-Head_and_Esophagus\|World / Sample_Type by Project: Shred V9	LCE3D SPRR4 LCE3A LCE3E	5.22e-05	172	53	4	eb18aa179db1818f408c38e442ecfed8582d7dbc
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCE1B LCE1E LCE1D LCE1F	5.34e-05	173	53	4	0f9c1d3298e59e6d22bb3306f0f445f490be8bbd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EBF3 EBF1 ITGA9 ZFPM2	5.58e-05	175	53	4	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	COVID-19-Heart-Lymph_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EBF1 GRIN2B ITGA9 ZFPM2	5.83e-05	177	53	4	326fde0734ef0d7272693966d346ca479b9d8147
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	EBF1 GRIN2B ITGA9 ZFPM2	5.96e-05	178	53	4	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ELAPOR1 TACC2 USP54 ITGA9	5.96e-05	178	53	4	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VLDLR EBF3 EBF1 ZFPM2	6.78e-05	184	53	4	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	EBF1 GRIN2B ITGA9 ZFPM2	6.92e-05	185	53	4	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ELAPOR1 TACC2 USP54 ITGA9	6.92e-05	185	53	4	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	EBF1 GRIN2B ITGA9 ZFPM2	6.92e-05	185	53	4	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	ELAPOR1 TACC2 USP54 ITGA9	7.07e-05	186	53	4	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR ELAPOR2 PCLO STAU2	7.07e-05	186	53	4	f5468e03321ea2083e223eb0d92c3a9307039569
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ELAPOR2 RAB40C TACC2 USP54	7.22e-05	187	53	4	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	EBF1 GRIN2B ITGA9 ZFPM2	7.22e-05	187	53	4	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EBF1 GRIN2B ITGA9 ZFPM2	7.37e-05	188	53	4	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EBF1 GRIN2B ITGA9 ZFPM2	7.37e-05	188	53	4	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	COVID-19_Severe-HSPC\|COVID-19_Severe / disease group, cell group and cell class	PCLO ZNF667 ITGA9 BAALC	7.52e-05	189	53	4	96015439971e2e5b8d6294ca5a6b873c7774e925
ToppCell	COVID-19-lung-Lymphatic_EC\|lung / Disease (COVID-19 only), tissue and cell type	EBF1 GRIN2B ITGA9 ZFPM2	7.52e-05	189	53	4	c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3
ToppCell	COVID-19_Severe-HSPC\|World / disease group, cell group and cell class	PCLO ZNF667 ITGA9 BAALC	7.52e-05	189	53	4	555c0b13f1508b9e3712b36d77144e73e828bc76
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	EBF1 GRIN2B ITGA9 ZFPM2	7.68e-05	190	53	4	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EBF3 EBF1 ITGA9 ZFPM2	7.68e-05	190	53	4	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	EBF3 GREB1 EBF1 ZFPM2	7.68e-05	190	53	4	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EBF1 GRIN2B ITGA9 ZFPM2	7.68e-05	190	53	4	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	RANBP2 EBF1 PCM1 ZNF292	7.83e-05	191	53	4	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	GREB1 MED13L PCM1 ZNF292	7.99e-05	192	53	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	ELAPOR1 TACC2 USP54 ITGA9	7.99e-05	192	53	4	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PCLO RAB11A ITGA9 BAALC	8.32e-05	194	53	4	bc03d0f8dca9f4ba10db2f2274293f8b119e8951
ToppCell	wk_20-22-Endothelial-Lymph_endothelial-Lymphatic_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PCLO RAB11A ITGA9 BAALC	8.32e-05	194	53	4	640ff8da7084a9486fc2752493b8d8059ecf4ab7
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ELAPOR1 HABP2 MLXIP TMEM63A	8.49e-05	195	53	4	b67d4f34cae729c18275486d3b20c9dd7d5cbe79
ToppCell	wk_15-18-Endothelial-Lymph_endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PCLO RAB11A ITGA9 BAALC	8.65e-05	196	53	4	ff627244d7f5fd6a2ec009dae32d3509f0e2d95e
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EBF3 EBF1 GRIN2B ZFPM2	8.83e-05	197	53	4	5fbbc570a4e77c703f569a4f85ce2d8af67d6297
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ELAPOR2 ICAM4 TACC2 USP54	8.83e-05	197	53	4	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EBF1 GRIN2B ITGA9 ZFPM2	9.00e-05	198	53	4	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EBF1 GRIN2B ITGA9 ZFPM2	9.00e-05	198	53	4	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	EBF3 PCLO EBF1 GRIN2B	9.36e-05	200	53	4	68c90376e2779434e4ad8dc6dd3b44baa700e2f4
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	EBF3 PCLO EBF1 ZNF292	9.36e-05	200	53	4	ac0e023dbb383bbc46c5cc525431778be8f7ef46
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PCLO ELAPOR1 TACC2 TMEM63A	9.36e-05	200	53	4	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ELAPOR2 PCLO ELAPOR1 TACC2	9.36e-05	200	53	4	65c83a3f6ee2a10bcb5b95076696232c6373a7b4
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ELAPOR2 PCLO ELAPOR1 TACC2	9.36e-05	200	53	4	40e969883bc302e8fbc6b6ab9814529dc1472902
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT2-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	ELAPOR2 PCLO ELAPOR1 TACC2	9.36e-05	200	53	4	ad9cdc82a647d379abc713a56db0e11bb6494106
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2\|TCGA-Breast / Sample_Type by Project: Shred V9	LCE3D SPRR4 LCE3E	1.80e-04	92	53	3	cad8b1b74a412988b2ae4f6126b2186100a2cdc2
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid-6\|TCGA-Endometrium / Sample_Type by Project: Shred V9	ADGRE1 LCE2C LCE2A	3.13e-04	111	53	3	5129c4a5004e16f9504300a5bd5f3d76c93a28fe
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICAM4 ZRANB3 ZFPM2	4.03e-04	121	53	3	e82c9e10b98c8d7ad828cf8ac19a2342014be2ba
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8\|TCGA-Kidney / Sample_Type by Project: Shred V9	ANTXRL LCE1E LCE1A	4.23e-04	123	53	3	967f20fcb27c9989de93f4183038334105910175
ToppCell	VE-CD4-CD4_Treg\|VE / Condition, Cell_class and T cell subcluster	ICAM4 TACC2 USP54	4.86e-04	129	53	3	e89d414e1b23e1656747defa39f09b51944a2166
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TACC2 USP54 ITGA9	4.97e-04	130	53	3	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	facs-Marrow-B-cells-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HABP2 LCE3A LCE1F	6.56e-04	143	53	3	6df16bf0324661cd9707df69cb39f4b5498d6d49
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ELAPOR1 HABP2 ZFPM2	7.39e-04	149	53	3	24a7538b54b2a5291503c7493fefed4e45e8d710
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Cerebellum / BrainAtlas - Mouse McCarroll V32	KCNA3 GRIN2B ZFPM2	7.39e-04	149	53	3	6e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ELAPOR1 HABP2 ZFPM2	7.39e-04	149	53	3	cc6224c6b79f43b97adc1ce48ca4906bff2ad318
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor\|bone_marrow / Manually curated celltypes from each tissue	ZNF667 EBF1 BAALC	7.39e-04	149	53	3	078e1e5765e476ba85c23fb8f6892b6698cbcbdb
ToppCell	10x5'-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	EBF1 MLXIP BAALC	8.13e-04	154	53	3	8a8c3851888ab86ca2b13ccc042cde1fef8d88f8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EBF1 ITGA9 ZFPM2	8.28e-04	155	53	3	babcb9e548f04ace8157d506d27c5941c692c491
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ELAPOR1 GRIN2B TMEM63A	8.43e-04	156	53	3	58b9520fce6e259b36c3d59e82b712f5e7729e3e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ELAPOR2 ITGA9 ZFPM2	9.24e-04	161	53	3	fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF3 EBF1 ZFPM2	9.24e-04	161	53	3	a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KCNA3 EBF3 ZRANB3	9.24e-04	161	53	3	52556b89808e551540f33a13f57417a6696c2438
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ELAPOR2 ITGA9 ZFPM2	9.24e-04	161	53	3	c53c461fc721a7960cef86662f49e2a495520701
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF3 EBF1 ZFPM2	9.24e-04	161	53	3	4f25eeabb841b0b9204cdd4e71d5e131e7868184
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KCNA3 EBF3 ZRANB3	9.24e-04	161	53	3	54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KCNA3 EBF3 ZRANB3	9.24e-04	161	53	3	242891be849a4398fe8bea44875ae1ba57950944
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Club\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ZNF667 ELAPOR1 BAALC	9.41e-04	162	53	3	fe546c2272a70bb5f08e6e097b9accdb891eda23
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ELAPOR2 ITGA9 ZFPM2	9.41e-04	162	53	3	2ac02523348660e514d464f8f2434ee0c312d784
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ELAPOR1 GRIN2B TMEM63A	9.41e-04	162	53	3	ded08da888d8c481f0f96d1e0bfd03d617966910
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	ELAPOR1 TACC2 USP54	9.57e-04	163	53	3	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	IIF-Other-HSPC\|IIF / Disease, Lineage and Cell Type	PCLO ITGA9 BAALC	9.57e-04	163	53	3	1e0d38fbed38ac48478868a1480172a1a3f7c1b7
ToppCell	severe-HSPC\|severe / disease stage, cell group and cell class	VLDLR ITGA9 BAALC	9.92e-04	165	53	3	acd837d88ad3786c263f74651a6c0e02fa2fa2c5
ToppCell	COVID-19-kidney-Lymphatic_EC\|kidney / Disease (COVID-19 only), tissue and cell type	EBF1 ITGA9 ZFPM2	1.03e-03	167	53	3	97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GRIN2B ZRANB3 ZNF292	1.03e-03	167	53	3	3b717d33aaf1ef0869cc4bca8432ba8008875cc5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICAM4 ELAPOR1 GRIN2B	1.04e-03	168	53	3	b96a48552f4236a95bbcdce2f1b05041086d7101
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICAM4 ELAPOR1 GRIN2B	1.04e-03	168	53	3	b87fc63f9e35dfcfc46cb129ea569e73c5e018bb
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	ZNF667 ELAPOR1 ZFPM2	1.04e-03	168	53	3	d02eba7ece17edcdd47fd6b784c93910ce61090f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIN2B ITGA9 ZFPM2	1.08e-03	170	53	3	dcc64b73134e89ae37990d4878813b86ce91dae9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIN2B ITGA9 ZFPM2	1.08e-03	170	53	3	6035c92cd39c5ac54e7ec57d94888ee19f574639
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	ZNF667 ELAPOR1 ZFPM2	1.08e-03	170	53	3	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EBF1 MED13L BAALC	1.08e-03	170	53	3	a50e558d0b38100ccbdccb90647fe93e85bffd86
ToppCell	3'_v3-blood-Hematopoietic_progenitors-HSC-MPP\|blood / Manually curated celltypes from each tissue	PCLO ITGA9 BAALC	1.08e-03	170	53	3	1443d7fccc81088dd42dcbb9361e269872542274
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRIN2B ITGA9 ZFPM2	1.08e-03	170	53	3	c8c42eda44b61440c96b202e7f54650046eb95d3
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF354A RAB11A ITGA9	1.10e-03	171	53	3	686f95892c3909973c66c9a27159a070a068f175
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF354A RAB11A ITGA9	1.10e-03	171	53	3	f7ba03e7bdb687f93782c936c7b3374cc5b3b77c
ToppCell	PND14-Endothelial-Endothelial_lymphatic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF354A RAB11A ITGA9	1.10e-03	171	53	3	d0ac50071a3854d02113c455fcc940a6ec59bbb9
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF354A RAB11A ITGA9	1.10e-03	171	53	3	fbf8e9db00573adcada4b25730e191417b7c9999
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EBF3 GREB1 EBF1	1.12e-03	172	53	3	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	EBF1 ITGA9 ZFPM2	1.14e-03	173	53	3	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	ELAPOR2 ELAPOR1 ADGRE1	1.16e-03	174	53	3	390bd41ef114464f3db3e0cac4e67fe7571b4c23
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 USP54 ITGA9	1.16e-03	174	53	3	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EBF3 GRIN2B ZFPM2	1.17e-03	175	53	3	9a96a946db731ba24c9be34bedebf1f4a1372b9e
Drug	beta-damascenone	LCE1C LCE1B LCE1D LCE1F	2.48e-07	24	52	4	ctd:C075388
Disease	atopic eczema	LCE5A LCE1C LCE1E LCE1D LCE3A LCE1F LCE3E	1.93e-07	252	49	7	EFO_0000274
Disease	psoriasis, COVID-19	LCE2A LCE2B	2.70e-06	2	49	2	EFO_0000676, MONDO_0100096
Disease	psoriasis	LCE3D EBF1 MLXIP LCE3B LCE3A LCE3E	5.95e-06	273	49	6	EFO_0000676
Disease	vitamin D measurement	LCE3D LCE5A LCE1C LCE1B LCE1A LCE3E	1.93e-05	336	49	6	EFO_0004631
Disease	vascular endothelial growth factor A, isoform 121 measurement	VLDLR ZFPM2	9.65e-05	9	49	2	EFO_0020847
Disease	vascular endothelial growth factor A measurement	VLDLR ZFPM2	1.76e-04	12	49	2	EFO_0010804
Disease	response to olanzapine	ZFPM2 LCE3E	2.80e-04	15	49	2	GO_0097333
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	VLDLR ZFPM2	3.19e-04	16	49	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	Neurodevelopmental Disorders	GRIN2B MED13L ZNF292	5.03e-04	93	49	3	C1535926
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	GRIN2B ADGRE1	9.93e-04	28	49	2	DOID:1094 (implicated_via_orthology)
Disease	hair morphology	LCE5A LCE3E	1.07e-03	29	49	2	EFO_0005038
Disease	breast carcinoma	VLDLR HABP2 TACC2 GREB1 EBF1 PCM1 ZFPM2	1.39e-03	1019	49	7	EFO_0000305
Disease	neutrophil count	VLDLR SPRR5 RAB11A ELAPOR1 SPRR4 ZRANB3 ZFPM2 ZNF292	1.85e-03	1382	49	8	EFO_0004833
Disease	nasopharyngeal neoplasm	PCLO ADGRE1 ITGA9	2.04e-03	151	49	3	EFO_0004252
Disease	childhood onset asthma	SPRR5 LCE5A LCE1C LCE1D	2.29e-03	334	49	4	MONDO_0005405
Disease	interleukin 12 measurement	VLDLR ZFPM2	3.53e-03	53	49	2	EFO_0004753
Disease	vascular endothelial growth factor measurement	VLDLR ZFPM2	3.93e-03	56	49	2	EFO_0004762
Disease	Psoriasis	LCE3D LCE3B	4.07e-03	57	49	2	C0033860
Disease	Pustulosis of Palms and Soles	LCE3D LCE3B	4.07e-03	57	49	2	C0030246
Disease	atopic asthma	LCE5A LCE1C LCE1D	4.43e-03	199	49	3	EFO_0010638
Disease	psoriasis vulgaris	LCE3B LCE3A	4.64e-03	61	49	2	EFO_1001494

Protein segments in the cluster

Peptide	Gene	Start	Entry
QAQTLCNPKSCLQPS	ANTXRL	566	A6NF34
CIACQNPGKQNQTTS	RANBP2	1626	P49792
SATKCIACQNPGKQN	RANBP2	1681	P49792
PPTTENKPKVQCCQN	RAB11A	201	P62491
PQSPPQNCSRSNCKI	RAB40C	266	Q96S21
CPAKGNQCCPPQQNQ	SMCP	11	P49901
SCPQAQNQCPLFLKA	MED13L	2116	Q71F56
ITQNLLNSPKQCPCG	GREB1	931	Q4ZG55
QACVPCGPGTKNNKI	ELAPOR1	636	Q6UXG2
CEKNGNLKQPSPNGN	ZFPM2	916	Q8WW38
KDPPNFNTCTECKNQ	PCLO	1071	Q9Y6V0
KNDQNNCPVKPCYLN	PCM1	1861	Q15154
CTTNNNPNSCVNIKK	KCNA3	556	P22001
KCQSLQCKGEPQPSS	TMEM63A	371	O94886
KEACIPCGPGSKNNQ	ELAPOR2	651	A8MWY0
EKGNCSFQKNPTPCI	ITGA9	851	Q13797
PQNNCSGKSDPKNVA	MLXIP	701	Q9HAP2
APFSGNKCQKVQNTC	HABP2	101	Q14520
FLKCNQNCLKNAGNP	EBF1	191	Q9UH73
NPEKKTNCETQCPNP	BAALC	76	Q8WXS3
MSCQQSQQQCQPPPK	LCE1A	1	Q5T7P2
MSCQQNQQQCQPPPK	LCE1B	1	Q5T7P3
MSCQQSQQQCQPPPK	LCE1C	1	Q5T751
MSCQQSQQQCQPPPK	LCE1D	1	Q5T752
MSCQQSQQQCQPPPK	LCE1E	1	Q5T753
MSCQQSQQQCQPPPK	LCE1F	1	Q5T754
MSCQQNQQQCQPPPK	LCE2A	1	Q5TA79
MSCQQNQQQCQPPPK	LCE2B	1	O14633
MSCQQNQQQCQPPPK	LCE2C	1	Q5TA81
MSCQQNQQQCQPPPK	LCE2D	1	Q5TA82
MSCQQNQQQCQPPPK	LCE3A	1	Q5TA76
MSCQQNQQQCQPLPK	LCE3B	1	Q5TA77
MSCQQNQQQCQPPPK	LCE3D	1	Q9BYE3
MSCQQNQKQCQPPPK	LCE3E	1	Q5T5B0
MSCQQNQQQCQPPPK	LCE4A	1	Q5TA78
MSCQQSQQQCQPPPK	LCE5A	1	Q5TCM9
KSCQPQNLLTSGCQP	KRTAP26-1	151	Q6PEX3
FLKCNQNCLKNAGNP	EBF3	191	Q9H4W6
PGKSVQLNCSNSCPQ	ICAM4	61	Q14773
QSPQPCGPNSSCKNL	ADGRE1	86	Q14246
PPNQCNKSGQSICQK	ZNF667	96	Q5HYK9
KENCPACSQLPQNIQ	UBA3	361	Q8TBC4
EEPRNPNCQGSCKNQ	SPATA31A1	1086	Q5TZJ5
NNQAPPGSIAQDCKK	STAU2	551	Q9NUL3
IPAQQKCPSAQQASK	SPRR4	61	Q96PI1
MSQQKQKQCAPPQQC	SPRR5	1	A0A1B0GTR4
DKVNKPFVCQNQGCN	ZNF292	1896	O60281
KETCCTGQGPNKSQQ	TACC2	981	O95359
LCKACNPQPNGENAI	PLBD2	491	Q8NHP8
PPKCEIQGNSLKQNS	ZNF354A	186	O60765
QQPTCQTKQACKANS	ZRANB3	916	Q5FWF4
CPDPVQKTNQCLQGQ	USP54	1086	Q70EL1
NCKNVNQCLGPGKFK	VLDLR	311	P98155
ICIGNQSNPCVPNNK	GRIN2B	1446	Q13224